Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-048553
Filing Date
2024-11-19
Accepted
2024-11-19 18:35:04
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1732059298.html 3  
1 FORM 3 wk-form3_1732059298.xml 3 3847
  Complete submission text file 0001628280-24-048553.txt   5355
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451
Business Address
Reilly Joseph James (Reporting) CIK: 0002044416 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 241477726